FY2025 · ended Dec 31, 2025 · Revenue $461,452, -68.5% YoY · Filed Mar 31, 2026
Positron Corporation (POSC) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $461,452 and a net loss of $10.6 million. As of Jun 30, 2026 it held $357,173 in cash and investments and $306,566 in total debt.
Revenue
$461,452
-68.5% vs prior year
Net income
$-10.60M
-310.3% vs prior year
Operating cash flow
$-4.70M
-54.3% vs prior year
Free cash flow
$-3.06M
-32.4% vs prior year
EPS
$-0.34
Dividend per share
None
Shares outstanding
32.85M
-99.4% vs prior year
Net cash
$50,607
as of Jun 30, 2026
Operating margin
-2275.1%
FY 2025
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- POSC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Westmount, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 844985
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2014 Dec 31, 2014 |
FY 2013 Dec 31, 2013 |
FY 2012 Dec 31, 2012 |
FY 2011 Dec 31, 2011 |
|---|---|---|---|---|---|
| Revenue | $461,452 | $1.5M | $1.6M | $2.8M | $6.7M |
| Operating income | -$10.5M | -$2.7M | -$3.3M | -$4.7M | -$4.4M |
| Net income | -$10.6M | -$2.6M | -$7.1M | -$8.0M | -$6.1M |
| Diluted EPS | -$0.34 | — | — | — | — |
| Operating cash flow | -$4.7M | — | -$3.0M | -$2.2M | -$4.1M |
| Free cash flow | — | — | -$3.1M | -$2.3M | -$4.1M |
| Total assets | $4.0M | $1.9M | $3.9M | $2.7M | $2.3M |
| Total liabilities | $2.6M | $2.7M | $15.1M | $8.9M | — |
| Stockholders' equity | $1.4M | -$837,000 | -$11.2M | -$6.2M | -$2.9M |
| Cash and investments | $2.5M | $208,000 | $1.7M | $243,000 | $1,000 |
| Total debt | $337,984 | $1.1M | — | $689,000 | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 18, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 30, 2025 | Dec 23, 2025 |
All 325 Positron Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.